Live Event: Nurses at the forefront of change

Past

    No event(s) found.

Upcoming Events

Young Innovators

Nour Majbour

QABY Biotech
QABY is a biotech start-up encompassing novel antibodies, innovative assays, unique biomarkers and long-standing know-how tackling neurodegenerative diseases. Our technologies would enable early detection of neurodegenerative diseases, assessing treatment response and monitoring disease progression thus accelerating the reach for therapeutic solutions and improving the quality of life for patients living with such devastating diseases. Our key activities include: 1) Research & development (R&D); Developing new research tools and assays and discovering new disease targets based on scientific discoveries, 2) Providing a service; QABY technologies have been selected by several pharma companies as part of their clinical trials, 3) Antibodies & kits; selling antibodies and kits directly to end users.

Meet the Creators

Add Your Heading Text Here

Add Your Heading Text Here

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Meet the Innovator

Speaker Name

Speaker Position

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Innovator Name

Innovation Name

Description

Meet the Creators

2020

Unheeded Warnings Mitigating the Impact of Climate Change on Communicable Diseases

Jeremy Hess, Rachel Lowe, Muna Al Maslamani, Laura-Lee Boodram, Anna Stewart Ibarra, Judith Wasserheit

With the emergent threat of COVID-19, this report focuses on threatening diseases that are a by-product of climate change and what type of policy measures should be intact to deal with this head-on.